Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Lowers Price Target to $93

Benzinga · 1d ago
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.